A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of SR-0379 in Participants with Skin Ulcer

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2031210266

Enrollment

120

Registered

2021-08-20

Start date

2021-08-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

skin ulcer

Interventions

SR-0379 or placebo spray

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients must have a wound requiring wound bed preparation in advance of planned surgical closure (including suturing, grafts or flaps)

Exclusion criteria

Exclusion criteria: Presence of untreated ulcer infection (redness, swelling, pus, foul odor, fever)

Design outcomes

Primary

Measure	Time frame
The days to simple surgical intervention (ncluding suturing, grafts or flaps)	—

Contacts

Public ContactHideki Tomioka

FunPep Co., Ltd.

htomioka@funpep.co.jp+81-6-6369-7957

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026